Biotech

All Articles

Navigator increases $100M to build brand new autoimmune pipeline

.Navigator Medicines has actually outfitted itself along with $one hundred million in set A funds as...

Duality seeks money for ADC trials as IPO surge infects Asia

.China's Duality Biotherapeutics has filed (PDF) documentation for a Hong Kong IPO, looking for a hi...

YolTech markets China liberties to gene editing and enhancing therapy for $29M

.Four months after Chinese gene editing firm YolTech Therapies took its own cholesterol disease-focu...

Addex sell increases after Indivior offers up to $300M for compound

.Indivior is getting a small particle allosteric modulator made to treat drug make use of ailment fr...

Molecular Allies modifies AML trial over 'suboptimal exposure'

.Molecular Partners has pinpointed "suboptimal visibility" to its tetra-specific T-cell engager as t...

Despite mixed market, a financial backing resurgence could be coming in Europe: PitchBook

.While the biotech assets scene in Europe has actually reduced rather following a COVID-19 funding b...

8 months after a $213M fundraise, genetics publisher Tome helps make decreases

.After bring up $213 million in 2023-- among the year's most extensive exclusive biotech shots-- Vol...

BioMarin constructs director group with biotech vets-- Chutes &amp Ladders

.Accept to recently's Chutes &amp Ladders, our summary of notable leadership hirings, shootings as w...

Biopharma Q2 VC struck highest level because '22, while M&ampA slowed

.Equity capital backing into biopharma rose to $9.2 billion across 215 deals in the second one-fourt...

Bicara, Zenas seek IPOs to push late-phase resources toward market

.Bicara Therapeutics as well as Zenas Biopharma have delivered new impetus to the IPO market with fi...